Skip to main content
SpringerLink
Log in

Precursor B and Precursor T-Cell Lymphoblastic Lymphoma

  • Chapter
Pediatric Lymphomas

Part of the book series: Pediatric Oncology ((PEDIATRICO))

  • 988 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abromowitch M, Sposto R, Perkins S et al (2000). Outcome of Children’s Cancer Group (CCG) 5941: A Pilot Study for the Treatment of Newly Diagnosed Pediatric Patients with Disseminated Lymphoblastic Lymphoma. Proc ASCO 19: 583

    Google Scholar 

  • Alizadeh AA, Eisen MB et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403(6769): 503–511

    Article  PubMed  CAS  Google Scholar 

  • Amylon MD, Shuster J et al (1999) Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Leukemia 13(3): 335–342

    Article  PubMed  CAS  Google Scholar 

  • Anderson JR, Jenkin RD et al (1993) Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin’s lymphoma: a report of CCG-551 from the Childrens Cancer Group. J Clin Oncol 11(6): 1024–32

    PubMed  CAS  Google Scholar 

  • Anderson JR, Wilson JF et al (1983) Childhood non-Hodgkin’s lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2). N Engl J Med 308(10): 559–565

    Article  PubMed  CAS  Google Scholar 

  • Asselin BL, Shuster J, Amylon M, Halperin E, Hutchison R, Lipshultz S, Camitta B (2001) Improved Event-Free Survival (EFS) with High Dose Methotrexate (HDM) in T-Cell Lymphoblastic Leukemia (T-ALL) and Advanced Lymphoblastic Lymphoma (T-NHL): a Pediatric Oncology Group (POG) Study. Proc ASCO 20: 367

    Google Scholar 

  • Bash RO, Crist WM et al (1993) Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study. Blood 81(8): 2110–7

    PubMed  CAS  Google Scholar 

  • Bearman RM, Winberg CD et al (1981) Terminal deoxynucleotidyl transferase activity in neoplastic and nonneoplastic hematopoietic cells. Am J Clin Pathol 75(6): 794–802

    PubMed  CAS  Google Scholar 

  • Berg SL, Blaney SM et al (2005) Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children’s Oncology Group. J Clin Oncol 23(15): 3376–3382

    Article  PubMed  CAS  Google Scholar 

  • Bernard A, Boumsell L et al (1981) Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. Blood 57(6): 1105–1110

    PubMed  CAS  Google Scholar 

  • Bleyer WA (1990) The impact of childhood cancer on the United States and the world. CA Cancer J Clin 40(6):355–367

    PubMed  CAS  Google Scholar 

  • Boehm T, Foroni L et al (1991) The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc Natl Acad Sci USA 88(10): 4367–4371

    Article  PubMed  CAS  Google Scholar 

  • Bohlander SK, Muschinsky V et al (2000) Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients. Leukemia 14(1): 93–99

    Article  PubMed  CAS  Google Scholar 

  • Braziel RM, Keneklis T et al (1983) Terminal deoxynucleotidyl transferase in non-Hodgkin’s lymphoma. Am J Clin Pathol 80(5): 655–659

    PubMed  CAS  Google Scholar 

  • Campana D, Coustan-Smith E, Sandlund J, Abromowitch M (2005) A Novel Approach for Staging and Minimal Residual Disease Detection in T-cell Lymphoblastic Lymphoma-A Children’s Oncology Group Study. Ann Oncol 16[Suppl 5]: 62

    Google Scholar 

  • Cossman J, Chused TM et al (1983) Diversity of immunological phenotypes of lymphoblastic lymphoma. Cancer Res 43(9): 4486–4490

    PubMed  CAS  Google Scholar 

  • Coustan-Smith E, Gajjar A et al (2004) Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse. Leukemia 18(3): 499–504

    Article  PubMed  CAS  Google Scholar 

  • Coustan-Smith E, Sancho J et al (2002a) Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia. Blood 100(1): 52–58

    Article  PubMed  CAS  Google Scholar 

  • Coustan-Smith E, Sancho J et al (2002b) Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemia. Blood 100(7): 2399–2402

    Article  PubMed  CAS  Google Scholar 

  • Coustan-Smith E, Behm FG et al (1998) Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet 351(9102): 550–554

    Article  PubMed  CAS  Google Scholar 

  • Dahl GV, Rivera G et al (1985) A novel treatment of childhood lymphoblastic non-Hodgkin’s lymphoma: early and intermittent use of teniposide plus cytarabine. Blood 66(5): 1110–1114

    PubMed  CAS  Google Scholar 

  • Ferrando AA, Look AT (2003) Gene expression profiling in T-cell acute lymphoblastic leukemia. Semin Hematol 40(4): 274–280

    Article  PubMed  CAS  Google Scholar 

  • Ferrando AA, Neuberg DS et al (2004) Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia. Lancet 363(9408): 535–536

    Article  PubMed  CAS  Google Scholar 

  • Ferrando AA, Neuberg DS et al (2002) Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1(1): 75–87

    Article  PubMed  CAS  Google Scholar 

  • Gajjar A, Ribeiro R et al (1995) Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia. Blood 86(4): 1292–1295

    PubMed  CAS  Google Scholar 

  • Garrett KM, Hoffer FA et al (2002) Interventional radiology techniques for the diagnosis of lymphoma or leukemia. Pediatr Radiol 32(9): 653–662

    Article  PubMed  Google Scholar 

  • Gaynon PS, Desai AA et al (1997) Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review. Cancer 80(9): 1717–1726

    Article  PubMed  CAS  Google Scholar 

  • Gaynon PS, Bleyer WA et al (1990) Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features. Med Pediatr Oncol 18(4): 273–279

    PubMed  CAS  Google Scholar 

  • Goldberg JM, Silverman LB et al (2003) Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience. J Clin Oncol 21(19): 3616–3622

    Article  PubMed  Google Scholar 

  • Gouttefangeas C, Bensussan A et al (1990) Study of the CD3-associated T-cell receptors reveals further differences between T-cell acute lymphoblastic lymphoma and leukemia. Blood 75(4): 931–934

    PubMed  CAS  Google Scholar 

  • Head DR, Behm FG (1995) Acute lymphoblastic leukemia and the lymphoblastic lymphomas of childhood. Semin Diagn Pathol 12(4): 325–334

    PubMed  CAS  Google Scholar 

  • Hsu HL, Wadman I et al (1994) Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells. Proc Natl Acad Sci USA 91(8): 3181–3185

    Article  PubMed  CAS  Google Scholar 

  • Hvizdala EV, Berard C et al (1988) Lymphoblastic lymphoma in children-a randomized trial comparing LSA2-L2 with the A-COP+ therapeutic regimen: a Pediatric Oncology Group Study. J Clin Oncol 6(1): 26–33

    PubMed  CAS  Google Scholar 

  • Ingram L, Rivera GK et al (1990) Superior vena cava syndrome associated with childhood malignancy: analysis of 24 cases. Med Pediatr Oncol 18(6): 476–481

    PubMed  CAS  Google Scholar 

  • Inhorn RC, Aster JC et al (1995) A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/ malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity. Blood 85(7):1881–1887

    PubMed  CAS  Google Scholar 

  • Jaffe ES, Harris NL et al (2001) Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, IARC Press

    Google Scholar 

  • Kahwash SB, Qualman SJ (2002) Cutaneous lymphoblastic lymphoma in children: report of six cases with precursor B-cell lineage. Pediatr Dev Pathol 5(1): 45–53

    Article  PubMed  Google Scholar 

  • Kennedy MA, Gonzalez-Sarmiento R et al (1991) HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24. Proc Natl Acad Sci USA 88(20): 8900–8904

    Article  PubMed  CAS  Google Scholar 

  • Kidd PG, Saminathan T et al (1997) Comparison of the cellularity and presence of residual leukemia in bone marrow aspirate and biopsy specimens in pediatric patients with acute lymphoblastic leukemia (ALL) at day 7–14 of chemotherapy. Med Pediatr Oncol 29(6): 541–543

    Article  PubMed  CAS  Google Scholar 

  • Kobrinsky NL, Sposto R et al (2001) Outcomes of treatment of children and adolescents with recurrent non-Hodgkin’s lymphoma and Hodgkin’s disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children’s Cancer Group Study CCG-5912. J Clin Oncol 19(9):2390–2396

    PubMed  CAS  Google Scholar 

  • Kostakoglu L, Coleman M et al (2002) PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin’s disease. J Nucl Med 43: 1018–1027

    PubMed  Google Scholar 

  • Kung FH, Harris MB et al (1999) Ifosfamide/carboplatin/etoposide (ICE), an effective salvaging therapy for recurrent malignant non-Hodgkin lymphoma of childhood: a Pediatric Oncology Group phase II study. Med Pediatr Oncol 32(3): 225–226

    Article  PubMed  CAS  Google Scholar 

  • Kung PC, Long JC et al (1978) Terminal deoxynucleotidyl transferase in the diagnosis of leukemia and malignant lymphoma. Am J Med 64(5): 788–794

    Article  PubMed  CAS  Google Scholar 

  • Kurtzberg J, Ernst TJ et al (2005) Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies. J Clin Oncol 23(15): 3396–3403

    Article  PubMed  CAS  Google Scholar 

  • LeMaistre CF, Saleh MN et al (1998) Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2. Blood 91(2): 399–405

    PubMed  CAS  Google Scholar 

  • Lemerle M, Gerard-Marchant R et al (1975) Natural history of non-Hodgkin’s lymphoma in children. A retrospective study of 190 cases. Br J Cancer 31[Suppl 2]:324–331

    Google Scholar 

  • Lin P, Jones D et al (2000) Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement. Am J Surg Pathol 24(11): 1480–1490

    Article  PubMed  CAS  Google Scholar 

  • Link MP, Shuster JJ et al (1997) Treatment of children and young adults with early-stage non-Hodgkin’s lymphoma. N Engl J Med 337(18): 1259–1266

    Article  PubMed  CAS  Google Scholar 

  • Link MP, Donaldson SS et al (1990) Results of treatment of childhood localized non-Hodgkin’s lymphoma with combination chemotherapy with or without radiotherapy. N Engl J Med 322(17): 1169–1174

    Article  PubMed  CAS  Google Scholar 

  • Link MP, Roper M et al (1983) Cutaneous lymphoblastic lymphoma with pre-B markers. Blood 61(5): 838–841

    PubMed  CAS  Google Scholar 

  • Loeffler J, Leopold K et al (1986) Emergency prebiopsy radiation for mediastinal masses:impact upon subsequent pathologic diagnosis and outcome. J Clin Oncol 4: 716–721

    PubMed  CAS  Google Scholar 

  • Lu M, Gong ZY et al (1991) The tcl-3 proto-oncogene altered by chromosomal translocation in T-cell leukemia codes for a homeobox protein. Embo J 10(10): 2905–2910

    PubMed  CAS  Google Scholar 

  • Magrath IT (2002) Malignant Non-Hodgkin’s Lymphomas in Children. In: Pizzo PA, Poplack DG (eds) Principles and Practice of Pediatric Oncology. Lippincott/ Williams & Wilkins, Philadelphia, pp. 661–705

    Google Scholar 

  • Maitra A, McKenna RW et al (2001) Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature. Am J Clin Pathol 115(6): 868–875

    Article  PubMed  CAS  Google Scholar 

  • McCaffrey R, Smoler DF et al (1973) Terminal deoxynucleotidyl transferase in a case of childhood acute lymphoblastic leukemia. Proc Natl Acad Sci USA 70(2): 521–525

    Article  PubMed  CAS  Google Scholar 

  • Mellentin JD, Smith SD et al (1989) lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif. Cell 58(1): 77–83

    Article  PubMed  CAS  Google Scholar 

  • Meyers L, Hakami N (1984) Pre-B cell cutaneous lymphoma in infancy: a unique clinical entity. Med Pediatr Oncol 12(4): 252–254

    PubMed  CAS  Google Scholar 

  • Millot F, Robert A et al (1997) Cutaneous involvement in children with acute lymphoblastic leukemia or lymphoblastic lymphoma. The Children’s Leukemia Cooperative Group of the European Organization of Research and Treatment of Cancer (EORTC). Pediatrics 100(1): 60–64

    Article  PubMed  CAS  Google Scholar 

  • Mora J, Filippa D et al (2003) Lymphoblastic lymphoma of childhood and the LSA2L2 protocol: 30 year experience at the Memorial-Sloan Kettering Cancer Center. Cancer 98: 1283–1291

    Article  PubMed  Google Scholar 

  • Mori N, Oka K et al (1988) Leu-4 (CD3) antigen expression in the neoplastic cells from T-ALL and T-lymphoblastic lymphoma. Am J Clin Pathol 90(3): 244–9

    PubMed  CAS  Google Scholar 

  • Murphy SB (1980) Classification, staging and end results of treatment of childhood non-Hodgkin’s lymphomas: dissimilarities from lymphomas in adults. Semin Oncol 7(3): 332–9

    PubMed  CAS  Google Scholar 

  • Murphy S, Jaffe ES (1984) Terminal transferase activity and lymphoblastic neoplasms. N Engl J Med 311(21): 1373–5

    Article  PubMed  CAS  Google Scholar 

  • Murphy SB, Fairclough DL et al (1989) Non-Hodgkin’s lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution. J Clin Oncol 7(2): 186–93

    PubMed  CAS  Google Scholar 

  • Naeem R, Singer S et al (1995) Translocation t(8;13)(p11;q11–12) in stem cell leukemia/lymphoma of T-cell and myeloid lineages. Genes Chromosomes Cancer 12(2): 148–51

    PubMed  CAS  Google Scholar 

  • Narita M, Shimizu K et al (1999) Consistent detection of CALM-AF10 chimaeric transcripts in haematological malignancies with t(10;11)(p13;q14) and identification of novel transcripts. Br J Haematol 105(4): 928–37

    Article  PubMed  CAS  Google Scholar 

  • National Cancer Institute (1982) NCI sponsored study of classifications of non-Hodgkin’s lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin’s Lymphoma Pathologic Classification Project. Cancer 49(10): 2112–35

    Article  Google Scholar 

  • Neth O, Seidemann K et al (2000) Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL-BFM 86 and 90. Med Pediatr Oncol 35(1): 20–7

    Article  PubMed  CAS  Google Scholar 

  • Olsen E, Duvic M et al (2001) Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. J Clin Oncol 19(2): 376–88

    PubMed  CAS  Google Scholar 

  • Parker SL, Tong T et al (1996) Cancer statistics, 1996. CA Cancer J Clin 46(1): 5–27

    PubMed  CAS  Google Scholar 

  • Patte C, Kalifa C et al (1992) Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma. Med Pediatr Oncol 20(2): 105–13

    PubMed  CAS  Google Scholar 

  • Pawson R, Dyer MJ et al (1997) Treatment of T-cell prolymphocytic leukemia with human CD52 antibody. J Clin Oncol 15(7): 2667–72

    PubMed  CAS  Google Scholar 

  • Percy CL, Smith MA et al (1999) Lymphomas and Reticuloendothelial Neoplasms. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995. NIH Pub. no. 99-4649: 35–49

    Google Scholar 

  • Pinkel D, Johnson W, Aur R (1975) Non-Hodgkin’s lymphoma in children. Br J Cancer 31(suppl): 298–323

    Google Scholar 

  • Pui CH, Crist WM (1992) Cytogenetic abnormalities in childhood acute lymphoblastic leukemia correlates with clinical features and treatment outcome. Leuk Lymphoma 7(4): 259–74

    PubMed  CAS  Google Scholar 

  • Pui CH, Mahmoud HH et al (2001) Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. J Clin Oncol 19(3):697–704

    PubMed  CAS  Google Scholar 

  • Pui CH, Relling MV et al (1997) Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies. Leukemia 11(11): 1813–6

    Article  PubMed  CAS  Google Scholar 

  • Pui CH, Behm FG et al (1993) Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 82(2): 343–62

    PubMed  CAS  Google Scholar 

  • Pusill-Wachtsmuth B, Schrappe M, Zimmermann M et al (2003) Impact of Cranial Radiotherapy on CNS Prophylaxis in Children and Young Adolescents with CNS-negative lymphoblastic lymphoma stage III/IV treated with an intensive ALL-type chemotherapy. Blood 102(11): 144a

    Google Scholar 

  • Reiter A, Schrappe M et al (1994) Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 84(9): 3122–33

    PubMed  CAS  Google Scholar 

  • Reiter A, Schrappe M et al (2000) Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood 95(2): 416–21

    PubMed  CAS  Google Scholar 

  • Roper M, Crist WM et al (1983) Monoclonal antibody characterization of surface antigens in childhood T-cell lymphoid malignancies. Blood 61(5): 830–7

    PubMed  CAS  Google Scholar 

  • Rosenwald A, Wright G et al (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346(25): 1937–47

    Article  PubMed  Google Scholar 

  • Sandlund J, Bowman L et al (2002a) Intensive chemotherapy with hematopoietic stem cell support for children with recurrent or refractory NHL. Cytotherapy 4:253–258

    Article  PubMed  CAS  Google Scholar 

  • Sandlund JT, Harrison PL et al (2002b) Persistence of lymphoblasts in bone marrow on day 15 and days 22 to 25 of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemia. Blood 100(1): 43–7

    Article  PubMed  CAS  Google Scholar 

  • Sandlund JT, Murphy SB et al (2000) CNS involvement in children with newly diagnosed non-Hodgkin’s lymphoma. J Clin Oncol 18(16): 3018–24

    PubMed  CAS  Google Scholar 

  • Sandlund JT, Ribeiro R et al (1994) Factors contributing to the prognostic significance of bone marrow involvement in childhood non-Hodgkin lymphoma. Med Pediatr Oncol 23(4): 350–3

    PubMed  CAS  Google Scholar 

  • Schultz KR, Massing B et al (1997) Importance of the day 7 bone marrow biopsy as a prognostic measure of the outcome in children with acute lymphoblastic leukemia. Med Pediatr Oncol 29(1): 16–22

    Article  PubMed  CAS  Google Scholar 

  • Shamberger R, Holzman R et al (1995) Prospective evaluation by computed tomography and pulmonary function tests of children with mediastinal masses. Surgery 118: 468–471

    Article  PubMed  CAS  Google Scholar 

  • Sheibani K, Nathwani BN et al (1987a) Antigenically defined subgroups of lymphoblastic lymphoma. Relationship to clinical presentation and biologic behavior. Cancer 60(2): 183–90

    Article  PubMed  CAS  Google Scholar 

  • Sheibani K, Winberg CD et al (1987b) Lymphoblastic lymphoma expressing natural killer cell-associated antigens: a clinicopathologic study of six cases. Leuk Res 11(4): 371–7

    Article  PubMed  CAS  Google Scholar 

  • Shikano T, Arioka H et al (1994) Acute lymphoblastic leukemia and non-Hodgkin’s lymphoma with mediastinal mass — a study of 23 children; different disorders or different stages? Leuk Lymphoma 13(1–2): 161–7

    Article  PubMed  CAS  Google Scholar 

  • Shikano T, Ishikawa Y et al (1992) Cytogenetic characteristics of childhood non-Hodgkin lymphoma. Cancer 70(3): 714–9

    Article  PubMed  CAS  Google Scholar 

  • Slap G, Brooks J, Schwartz J (1984) When to perform biopsies of enlarged peripheral lymph nodes in young patients. JAMA 252:1321–26

    Article  PubMed  CAS  Google Scholar 

  • Soslow RA, Bhargava V et al (1997) MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities. Hum Pathol 28(10): 1158–65

    Article  PubMed  CAS  Google Scholar 

  • Steinherz PG, Gaynon PS et al (1996) Cytoreduction and prognosis in acute lymphoblastic leukemia — the importance of early marrow response: report from the Childrens Cancer Group. J Clin Oncol 14(2): 389–98

    PubMed  CAS  Google Scholar 

  • Swerdlow SH, Habeshaw JA et al (1985) T lymphoblastic lymphoma with LEU-7 positive phenotype and unusual clinical course: a multiparameter study. Leuk Res 9(1): 167–73

    Article  PubMed  CAS  Google Scholar 

  • Synold TW, Relling MV et al (1994) Blast cell methotrexatepolyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. J Clin Invest 94(5): 1996–2001

    Article  PubMed  CAS  Google Scholar 

  • Talpur R, Apisarnthanarax N et al (2002) Treatment of refractory peripheral T-cell lymphoma with denileukin diftitox (ONTAK). Leuk Lymphoma 43(1): 121–6

    Article  PubMed  Google Scholar 

  • Tubergen DG, Krailo MD et al (1995) Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin’s lymphoma: a Childrens Cancer Group study. J Clin Oncol 13(6): 1368–76

    PubMed  CAS  Google Scholar 

  • Weinstein HJ, Cassady JR et al (1983) Long-term results of the APO protocol (vincristine, doxorubicin [adriamycin], and prednisone) for treatment of mediastinal lymphoblastic lymphoma. J Clin Oncol 1(9): 537–41

    PubMed  CAS  Google Scholar 

  • Weiss LM, Bindl JM et al (1986) Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Blood 67(2): 474–8

    PubMed  CAS  Google Scholar 

  • Wollner N, Exelby PR et al (1979) Non-Hodgkin’s lymphoma in children: a progress report on the original patients treated with the LSA2-L2 protocol. Cancer 44(6): 1990–9

    Article  PubMed  CAS  Google Scholar 

  • Xia Y, Brown L et al (1991) TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia. Proc Natl Acad Sci USA 88(24): 11416–20

    Article  PubMed  CAS  Google Scholar 

  • Xiao S, Nalabolu SR et al (1998) FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome. Nat Genet 18(1): 84–7

    Article  PubMed  CAS  Google Scholar 

  • Yeoh EJ, Ross ME et al (2002) Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1(2): 133–43

    Article  PubMed  CAS  Google Scholar 

  • Young JL Jr, Ries LG et al (1986) Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer 58(2 Suppl): 598–602

    Article  PubMed  Google Scholar 

  • Ziegler J (1977) Treatment results of 54 American patients with Burkitt’s lymphoma are similar to the African experience. N Engl J Med 297:75–80

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology-Oncology, St. Jude Children’s Research Hospital College of Medicine, University of Tennessee, 332 North Lauderdale, Memphis, TN, 28105, USA

    J. T. Sandlund M.D.

Authors
  1. J. T. Sandlund M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pediatrics, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA

    Howard J. Weinstein

  2. Department of Pediatrics, University of Tennessee Health Science Center College of Medicine, 332 North Lauderdale, Memphis, TN, 28105, USA

    Melissa M. Hudson

  3. Department of Hematology-Oncology, St. Jude Children’s Research Hospital, 332 North Lauderdale, Memphis, TN, 28105, USA

    Melissa M. Hudson

  4. School of Medicine, Department of Hematology-Oncology, Stanford University, 300 Pasteur Drive, Stanford, CA, 94305-5208, USA

    Michael P. Link

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sandlund, J.T. (2007). Precursor B and Precursor T-Cell Lymphoblastic Lymphoma. In: Weinstein, H.J., Hudson, M.M., Link, M.P. (eds) Pediatric Lymphomas. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68753-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-68753-5_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20356-8

  • Online ISBN: 978-3-540-68753-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation